N. R. Bohidar

2.5k total citations
29 papers, 951 citations indexed

About

N. R. Bohidar is a scholar working on Analytical Chemistry, Pharmaceutical Science and Food Science. According to data from OpenAlex, N. R. Bohidar has authored 29 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Analytical Chemistry, 5 papers in Pharmaceutical Science and 5 papers in Food Science. Recurrent topics in N. R. Bohidar's work include Analytical Methods in Pharmaceuticals (6 papers), Drug Solubulity and Delivery Systems (5 papers) and Pesticide Residue Analysis and Safety (4 papers). N. R. Bohidar is often cited by papers focused on Analytical Methods in Pharmaceuticals (6 papers), Drug Solubulity and Delivery Systems (5 papers) and Pesticide Residue Analysis and Safety (4 papers). N. R. Bohidar collaborates with scholars based in United States, Switzerland and Belgium. N. R. Bohidar's co-authors include Pablo Yagupsky, David Greenberg, Oren Abramson, Paul M. Mendelman, Rimma Melamed, Lolita Piglansky, Joseph L. Ciminera, Nathan Mantel, Alexander Scriabine and Kari S. Lankinen and has published in prestigious journals such as Clinical Infectious Diseases, Biometrics and The Journal of Infectious Diseases.

In The Last Decade

N. R. Bohidar

26 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. R. Bohidar United States 11 545 365 90 87 66 29 951
R E Garner United States 15 150 0.3× 76 0.2× 13 0.1× 157 1.8× 28 0.4× 28 760
J.Chris Jensen Germany 16 218 0.4× 19 0.1× 13 0.1× 108 1.2× 59 0.9× 24 1.0k
Robert Kulawy United States 21 383 0.7× 47 0.1× 15 0.2× 238 2.7× 34 0.5× 36 1.3k
Eric Pelfrene United Kingdom 8 481 0.9× 70 0.2× 7 0.1× 220 2.5× 75 1.1× 10 1.0k
F. Scaglione Italy 14 311 0.6× 48 0.1× 3 0.0× 189 2.2× 122 1.8× 66 806
Derek J. Sloan United Kingdom 20 802 1.5× 31 0.1× 11 0.1× 176 2.0× 21 0.3× 89 1.4k
Debra Hanna United States 18 508 0.9× 14 0.0× 18 0.2× 355 4.1× 42 0.6× 32 1.2k
Seunghoon Han South Korea 14 157 0.3× 10 0.0× 21 0.2× 131 1.5× 22 0.3× 76 752
Nicole Restrepo United States 11 75 0.1× 48 0.1× 11 0.1× 343 3.9× 19 0.3× 17 874
Véronique Joly France 20 251 0.5× 26 0.1× 3 0.0× 143 1.6× 25 0.4× 63 1.0k

Countries citing papers authored by N. R. Bohidar

Since Specialization
Citations

This map shows the geographic impact of N. R. Bohidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. R. Bohidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. R. Bohidar more than expected).

Fields of papers citing papers by N. R. Bohidar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. R. Bohidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. R. Bohidar. The network helps show where N. R. Bohidar may publish in the future.

Co-authorship network of co-authors of N. R. Bohidar

This figure shows the co-authorship network connecting the top 25 collaborators of N. R. Bohidar. A scholar is included among the top collaborators of N. R. Bohidar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. R. Bohidar. N. R. Bohidar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bucher, Michael, N. R. Bohidar, Lloyd Haskell, et al.. (2008). Vascular Effects of RWJ-676070, a Selective Combined V1a/V2 Vasopressin Receptor Antagonist. Clinical Pharmacology & Therapeutics. 85(2). 145–148. 1 indexed citations
2.
Kilpi, Terhi, H. Åhman, Janne J. Jokinen, et al.. (2003). Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: Randomised, controlled trial of a sevenvalent pneumococcal polysaccharide-meningococcal outer membrane protein c. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
3.
4.
Melamed, Rimma, Lolita Piglansky, David Greenberg, et al.. (1996). Reduction of Nasopharyngeal Carriage of Pneumococci during the Second Year of Life by a Heptavalent Conjugate Pneumococcal Vaccine. The Journal of Infectious Diseases. 174(6). 1271–1278. 381 indexed citations
5.
Bohidar, N. R., et al.. (1994). Detection of Discordant Content Uniformity Observations and Compendial Compliance. Drug Development and Industrial Pharmacy. 20(5). 815–839.
6.
Bohidar, N. R. & Norman R. Bohidar. (1994). Multivariate Analyses of a Production Formulation Optimization Experiment. Drug Development and Industrial Pharmacy. 20(13). 2165–2174. 3 indexed citations
7.
Bohidar, N. R. & Norman R. Bohidar. (1992). Construction of upper confidence limit of coefficient of variation for content uniformity. Drug Development and Industrial Pharmacy. 18(1). 21–37. 5 indexed citations
8.
Bohidar, N. R.. (1991). Short-term stability determination using SAS™. Drug Development and Industrial Pharmacy. 17(1). 39–54. 2 indexed citations
9.
Bohidar, N. R., et al.. (1991). Application of Simplex and Statistical Analysis for Correction of Pitting in Aqueous Film Coated Tablets. Drug Development and Industrial Pharmacy. 17(4). 609–615. 1 indexed citations
10.
Bohidar, N. R.. (1991). Determination of Geometric Standard Deviation for Dissolution. Drug Development and Industrial Pharmacy. 17(10). 1381–1387. 6 indexed citations
11.
Bohidar, N. R., et al.. (1982). Medicament Release from Suppository Bases I: Physicochemical Characteristics and Bioavailability of Indomethacin in Rabbits. Journal of Pharmaceutical Sciences. 71(8). 945–949. 26 indexed citations
12.
Scriabine, Alexander, Lauren Watson, Horace F. Russo, et al.. (1979). Diuretic and antihypertensive effects of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447).. Journal of Pharmacology and Experimental Therapeutics. 208(1). 148–154. 15 indexed citations
13.
Bohidar, N. R., et al.. (1979). A Comparative Evaluation of Four Automatic Weighing Systems. Drug Development and Industrial Pharmacy. 5(4). 335–348. 1 indexed citations
14.
Scriabine, Alexander, Charles S. Sweet, Carl T. Ludden, et al.. (1977). Some cardiovascular effects of ST-91 and clonidine. European Journal of Pharmacology. 43(4). 333–341. 35 indexed citations
15.
Mantel, Nathan, N. R. Bohidar, & Joseph L. Ciminera. (1977). Mantel-Haenszel analyses of litter-matched time-to-response data, with modifications for recovery of interlitter information.. PubMed. 37(11). 3863–8. 82 indexed citations
16.
Bohidar, N. R., et al.. (1975). Selecting Key Parameters in Pharmaceutical Formulations by Principal Component Analysis. Journal of Pharmaceutical Sciences. 64(6). 966–969. 18 indexed citations
17.
Scriabine, Alexander, Carl T. Ludden, & N. R. Bohidar. (1974). Potentiation of the Antihypertensive Action of Hydralazine by Timolol in Spontaneously Hypertensive Rats. Experimental Biology and Medicine. 146(2). 509–512. 8 indexed citations
18.
Bohidar, N. R., et al.. (1974). Disintgrability Characteristics of three Selected Tablet Excipients. 1(4). 331–347. 6 indexed citations
19.
Bohidar, N. R., et al.. (1973). Performance of Tablet Breaking Strength Testers I: Intralaboratory Comparison and Prediction. Journal of Pharmaceutical Sciences. 62(9). 1520–1524. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R E Garner Breakdown of academic impact, for papers by J.Chris Jensen Breakdown of academic impact, for papers by Robert Kulawy Breakdown of academic impact, for papers by Eric Pelfrene Breakdown of academic impact, for papers by F. Scaglione Breakdown of academic impact, for papers by Derek J. Sloan Breakdown of academic impact, for papers by Debra Hanna Breakdown of academic impact, for papers by Seunghoon Han Breakdown of academic impact, for papers by Nicole Restrepo Breakdown of academic impact, for papers by Véronique Joly
Rankless by CCL
2026